
Bristol Myers Squibb Gets EC Approval for Opdivo® + Yervoy® in Advanced Hepatocellular Carcinoma
Bristol Myers Squibb Gets EC Approval for Opdivo® + Yervoy® in Advanced Hepatocellular Carcinoma Bristol Myers Squibb (NYSE: BMY) has announced that the European Commission (EC) has granted approval for…











